Identification of neutral tumor evolution across cancer types

Nature Genetics

Volumn 48, Issue 3, 2016, Pages 238-244

  Williams, Marc J ^a,b   Werner, Benjamin ^c   Barnes, Chris P ^b   Graham, Trevor A ^a   Sottoriva, Andrea ^c  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLADDER CANCER; BREAST CANCER; CANCER GENETICS; CANCER GROWTH; CELL DIVISION; CHROMOSOMAL INSTABILITY; COLON ADENOCARCINOMA; COLON CANCER; COLORECTAL CANCER; COMPUTER MODEL; COPY NUMBER VARIATION; GENE DELETION; GENE DUPLICATION; GENE FREQUENCY; GENE MUTATION; GENOMICS; GLIOBLASTOMA; HUMAN; IN VIVO STUDY; KIDNEY CARCINOMA; LUNG CANCER; MALIGNANT TRANSFORMATION; MELANOMA; NEXT GENERATION SEQUENCING; NONHUMAN; PANCREAS CANCER; PRIORITY JOURNAL; SOMATIC MUTATION; SQUAMOUS CELL LUNG CARCINOMA; STOMACH CANCER; THYROID CANCER; CELL CLONE; GENETIC DRIFT; GENETICS; HIGH THROUGHPUT SEQUENCING; NEOPLASM; PROCEDURES;

CLONE CELLS; GENE FREQUENCY; GENETIC DRIFT; GENOMICS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; NEOPLASMS;

EID: 84959524739     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.3489     Document Type: Article

References (48)

1. Greaves M., & Maley C.C. Clonal evolution in cancer. Nature 481, 306-313 (2012
2. Basanta D., & Anderson A.R.A. Exploiting ecological principles to better understand cancer progression and treatment. Interface Focus 3, 20130020 (2013
3. Vogelstein B., et al. Cancer genome landscapes. Science 339, 1546-1558 (2013
4. Burrell R.A., McGranahan N., Bartek J., & Swanton C. The causes and consequences of genetic heterogeneity in cancer evolution. Nature 501, 338-345 (2013
5. Marusyk A., Almendro V., & Polyak K. Intra-tumour heterogeneity: a looking glass for cancer?. Nat. Rev. Cancer 12, 323-334 (2012
6. Polyak K. Tumor heterogeneity confounds and illuminates: a case for Darwinian tumor evolution. Nat. Med. 20, 344-346 (2014
7. Gerlinger M., et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N. Engl. J. Med. 366, 883-892 (2012
8. Baca S.C., et al. Punctuated evolution of prostate cancer genomes. Cell 153, 666-677 (2013
9. Tabassum D.P., & Polyak K. Tumorigenesis: it takes a village. Nat. Rev. Cancer 15, 473-483 (2015
10. Shou W., Bergstrom C.T., Chakraborty A.K., & Skinner F.K. Theory, models and biology. eLife 4, e07158 (2015
11. Sottoriva A., et al. A Big Bang model of human colorectal tumor growth. Nat. Genet. 47, 209-216 (2015
12. Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature 487, 330-337 (2012
13. Jesinghaus M., et al. Distinctive spatiotemporal stability of somatic mutations in metastasized microsatellite-stable colorectal cancer. Am. J. Surg. Pathol. 39, 1140-1147 (2015
14. Ohta T., & Gillespie J.H. Development of neutral and nearly neutral theories. Theor. Popul. Biol. 49, 128-142 (1996
15. Donnelly P., & Tavaré S. Coalescents and genealogical structure under neutrality. Annu. Rev. Genet. 29, 401-421 (1995
16. Durrett R., & Schweinsberg J. Approximating selective sweeps. Theor. Popul. Biol. 66, 129-138 (2004
17. Driessens G., Beck B., Caauwe A., Simons B.D., & Blanpain C. Defining the mode of tumour growth by clonal analysis. Nature 488, 527-530 (2012
18. Luria S.E., & Delbrück M. Mutations of bacteria from virus sensitivity to virus resistance. Genetics 28, 491-511 (1943
19. Griffiths R.C., & Tavaré S. The age of a mutation in a general coalescent. Communications in Statistics 14, 273-295 (1998
20. Maruvka Y.E., Kessler D.A., & Shnerb N.M. The birth-death-mutation process: a new paradigm for fat tailed distributions. PLoS One 6, e26480 (2011
21. Durrett R. Population genetics of neutral mutations in exponentially growing cancer cell populations. Ann. Appl. Probab. 23, 230-250 (2013
22. Kessler D.A., & Levine H. Large population solution of the stochastic Luria-Delbruck evolution model. Proc. Natl. Acad. Sci. USA 110, 11682-11687 (2013
23. Bak P., Tang C., & Wiesenfeld K. Self-organized criticality: an explanation of the 1/f noise. Phys. Rev. Lett. 59, 381-384 (1987
24. Jones S., et al. Comparative lesion sequencing provides insights into tumor evolution. Proc. Natl. Acad. Sci. USA 105, 4283-4288 (2008
25. Bozic I., et al. Accumulation of driver and passenger mutations during tumor progression. Proc. Natl. Acad. Sci. USA 107, 18545-18550 (2010
26. Sun S., Klebaner F., & Tian T. A new model of time scheme for progression of colorectal cancer. BMC Syst. Biol. 8 (suppl. 3), S2 (2014
27. Helleday T., Eshtad S., & Nik-Zainal S. Mechanisms underlying mutational signatures in human cancers. Nat. Rev. Genet. 15, 585-598 (2014
28. Wang K., et al. Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer. Nat. Genet. 46, 573-582 (2014
29. De Bruin E.C., et al. Spatial and temporal diversity in genomic instability processes defines lung cancer evolution. Science 346, 251-256 (2014
30. Zhang J., et al. Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing. Science 346, 256-259 (2014
31. Nik-Zainal S., et al. The life history of 21 breast cancers. Cell 149, 994-1007 (2012
32. Attolini C.S.-O., et al. A mathematical framework to determine the temporal sequence of somatic genetic events in cancer. Proc. Natl. Acad. Sci. USA 107, 17604-17609 (2010
33. Gerstung M., Eriksson N., Lin J., Vogelstein B., & Beerenwinkel N. The temporal order of genetic and pathway alterations in tumorigenesis. PLoS One 6, e27136 (2011
34. Sprouffske K., Pepper J.W., & Maley C.C. Accurate reconstruction of the temporal order of mutations in neoplastic progression. Cancer Prev. Res. (Phila.) 4, 1135-1144 (2011
35. Guo J., Guo H., & Wang Z. Inferring the temporal order of cancer gene mutations in individual tumor samples. PLoS One 9, e89244 (2014
36. Sottoriva A., et al. Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics. Proc. Natl. Acad. Sci. USA 110, 4009-4014 (2013
37. Wang Y., et al. Clonal evolution in breast cancer revealed by single nucleus genome sequencing. Nature 512, 155-160 (2014
38. Vermeulen L., et al. Defining stem cell dynamics in models of intestinal tumor initiation. Science 342, 995-998 (2013
39. Heng H.H.Q., et al. Stochastic cancer progression driven by non-clonal chromosome aberrations. J. Cell. Physiol. 208, 461-472 (2006
40. Navin N., et al. Tumour evolution inferred by single-cell sequencing. Nature 472, 90-94 (2011
41. Marusyk A., et al. Non-cell-autonomous driving of tumour growth supports sub-clonal heterogeneity. Nature 514, 54-58 (2014
42. Almendro V., et al. Inference of tumor evolution during chemotherapy by computational modeling and in situ analysis of genetic and phenotypic cellular diversity. Cell Reports 6, 514-527 (2014
43. Cibulskis K., et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat. Biotechnol. 31, 213-219 (2013
44. Koboldt D.C., et al. VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res. 22, 568-576 (2012
45. Andor N., et al. Pan-cancer analysis of the extent and consequences of intratumor heterogeneity. Nat. Med. doi: 10.1038/nm.3984 (30 November 2015
46. Niu B., et al. MSIsensor: microsatellite instability detection using paired tumor-normal sequence data. Bioinformatics 30, 1015-1016 (2014
47. Wang K., Li M., & Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 38, e164 (2010
48. Favero F., et al. Sequenza: allele-specific copy number and mutation profiles from tumor sequencing data. Ann. Oncol. 26, 64-70 (2015